RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers
The reputation of RUNX3 as a strong candidate for a tumor suppressor originated from studies of gastric carcinogenesis and now extends to a variety of other human cancers. The RUNX3 transcription factor is a downstream effector of the TGF‐β superfamily signaling pathway and has a critical role in th...
Gespeichert in:
Veröffentlicht in: | Journal of cellular biochemistry 2011-05, Vol.112 (5), p.1243-1249 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1249 |
---|---|
container_issue | 5 |
container_start_page | 1243 |
container_title | Journal of cellular biochemistry |
container_volume | 112 |
creator | Ito, Kosei |
description | The reputation of RUNX3 as a strong candidate for a tumor suppressor originated from studies of gastric carcinogenesis and now extends to a variety of other human cancers. The RUNX3 transcription factor is a downstream effector of the TGF‐β superfamily signaling pathway and has a critical role in the regulation of cell proliferation, cell death by apoptosis, and cell adhesion. Recently, RUNX3 was proposed as a gatekeeper linking oncogenic Wnt and anti‐oncogenic TGF‐β/BMPs signaling pathways in intestinal tumorigenesis in mouse and human. Also, loss of RUNX3 leading to elevated oncogenic Wnt activity was found to be a key event in inducing a precancerous state of the stomach. Chronic Helicobacter pylori infection is reported to inactivate RUNX3 in gastric carcinogenesis by multiple mechanisms. This “Prospect” focuses on our current understanding of the tumor suppressive functions of RUNX3 in the context of gastrointestinal cancer initiation and progression. J. Cell. Biochem. 112: 1243–1249, 2011. © 2011 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/jcb.23047 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_907169153</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>907169153</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4957-b0505b26f8705b1c1b4e832bd881111e01265d64ea85fe1c30c61357f74eae6e3</originalsourceid><addsrcrecordid>eNp1kEtLAzEUhYMotlYX_gHpTlxMm3dmllq0PkotYrG7kMlkhug0UydTtP_e1D5ceeFy4fCdw-UAcI5gD0GI--867WECqTgAbQQTEVFO6SFoQ0FghAnCLXDi_TuEMEkIPgYtjChnDOM2eHqZjmeka123croqjLO6q1wWtrHRn-Rt4VRpXbEmC-WburKuMb6xQe5q5bSp_Sk4ylXpzdn2dsD07vZ1cB-NnocPg-tRpGnCRJRCBlmKeR6LcJFGKTUxwWkWxyiMgQhzlnFqVMxygzSBmiPCRC6CZLghHXC5yV3U1ecyPCHn1mtTlsqZaullAgXiCWIkkFcbUteV97XJ5aK2c1WvJIJyXZ0M1cnf6gJ7sU1dpnOT7cldVwHob4AvW5rV_0nycXCzi4w2Dusb8713qPpDckEEk2_joZyxEZ1gPJAT8gP_jIXe</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>907169153</pqid></control><display><type>article</type><title>RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Ito, Kosei</creator><creatorcontrib>Ito, Kosei</creatorcontrib><description>The reputation of RUNX3 as a strong candidate for a tumor suppressor originated from studies of gastric carcinogenesis and now extends to a variety of other human cancers. The RUNX3 transcription factor is a downstream effector of the TGF‐β superfamily signaling pathway and has a critical role in the regulation of cell proliferation, cell death by apoptosis, and cell adhesion. Recently, RUNX3 was proposed as a gatekeeper linking oncogenic Wnt and anti‐oncogenic TGF‐β/BMPs signaling pathways in intestinal tumorigenesis in mouse and human. Also, loss of RUNX3 leading to elevated oncogenic Wnt activity was found to be a key event in inducing a precancerous state of the stomach. Chronic Helicobacter pylori infection is reported to inactivate RUNX3 in gastric carcinogenesis by multiple mechanisms. This “Prospect” focuses on our current understanding of the tumor suppressive functions of RUNX3 in the context of gastrointestinal cancer initiation and progression. J. Cell. Biochem. 112: 1243–1249, 2011. © 2011 Wiley‐Liss, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>ISSN: 1097-4644</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.23047</identifier><identifier>PMID: 21465522</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; Apoptosis - genetics ; BMP ; Cell Adhesion - genetics ; Core Binding Factor Alpha 3 Subunit - genetics ; Core Binding Factor Alpha 3 Subunit - metabolism ; gastrointestinal cancers ; Gastrointestinal Neoplasms - genetics ; Gastrointestinal Neoplasms - metabolism ; Gastrointestinal Neoplasms - pathology ; Helicobacter pylori ; Humans ; Intestinal Mucosa - metabolism ; Mice ; RUNX3 ; Signal Transduction - genetics ; TGF-beta ; Transforming Growth Factor beta - genetics ; Transforming Growth Factor beta - metabolism ; Tumor Suppressor Proteins - genetics ; Tumor Suppressor Proteins - metabolism ; Wnt ; Wnt Proteins - metabolism</subject><ispartof>Journal of cellular biochemistry, 2011-05, Vol.112 (5), p.1243-1249</ispartof><rights>Copyright © 2011 Wiley‐Liss, Inc.</rights><rights>Copyright © 2011 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4957-b0505b26f8705b1c1b4e832bd881111e01265d64ea85fe1c30c61357f74eae6e3</citedby><cites>FETCH-LOGICAL-c4957-b0505b26f8705b1c1b4e832bd881111e01265d64ea85fe1c30c61357f74eae6e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcb.23047$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcb.23047$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21465522$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ito, Kosei</creatorcontrib><title>RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>The reputation of RUNX3 as a strong candidate for a tumor suppressor originated from studies of gastric carcinogenesis and now extends to a variety of other human cancers. The RUNX3 transcription factor is a downstream effector of the TGF‐β superfamily signaling pathway and has a critical role in the regulation of cell proliferation, cell death by apoptosis, and cell adhesion. Recently, RUNX3 was proposed as a gatekeeper linking oncogenic Wnt and anti‐oncogenic TGF‐β/BMPs signaling pathways in intestinal tumorigenesis in mouse and human. Also, loss of RUNX3 leading to elevated oncogenic Wnt activity was found to be a key event in inducing a precancerous state of the stomach. Chronic Helicobacter pylori infection is reported to inactivate RUNX3 in gastric carcinogenesis by multiple mechanisms. This “Prospect” focuses on our current understanding of the tumor suppressive functions of RUNX3 in the context of gastrointestinal cancer initiation and progression. J. Cell. Biochem. 112: 1243–1249, 2011. © 2011 Wiley‐Liss, Inc.</description><subject>Animals</subject><subject>Apoptosis - genetics</subject><subject>BMP</subject><subject>Cell Adhesion - genetics</subject><subject>Core Binding Factor Alpha 3 Subunit - genetics</subject><subject>Core Binding Factor Alpha 3 Subunit - metabolism</subject><subject>gastrointestinal cancers</subject><subject>Gastrointestinal Neoplasms - genetics</subject><subject>Gastrointestinal Neoplasms - metabolism</subject><subject>Gastrointestinal Neoplasms - pathology</subject><subject>Helicobacter pylori</subject><subject>Humans</subject><subject>Intestinal Mucosa - metabolism</subject><subject>Mice</subject><subject>RUNX3</subject><subject>Signal Transduction - genetics</subject><subject>TGF-beta</subject><subject>Transforming Growth Factor beta - genetics</subject><subject>Transforming Growth Factor beta - metabolism</subject><subject>Tumor Suppressor Proteins - genetics</subject><subject>Tumor Suppressor Proteins - metabolism</subject><subject>Wnt</subject><subject>Wnt Proteins - metabolism</subject><issn>0730-2312</issn><issn>1097-4644</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEtLAzEUhYMotlYX_gHpTlxMm3dmllq0PkotYrG7kMlkhug0UydTtP_e1D5ceeFy4fCdw-UAcI5gD0GI--867WECqTgAbQQTEVFO6SFoQ0FghAnCLXDi_TuEMEkIPgYtjChnDOM2eHqZjmeka123croqjLO6q1wWtrHRn-Rt4VRpXbEmC-WburKuMb6xQe5q5bSp_Sk4ylXpzdn2dsD07vZ1cB-NnocPg-tRpGnCRJRCBlmKeR6LcJFGKTUxwWkWxyiMgQhzlnFqVMxygzSBmiPCRC6CZLghHXC5yV3U1ecyPCHn1mtTlsqZaullAgXiCWIkkFcbUteV97XJ5aK2c1WvJIJyXZ0M1cnf6gJ7sU1dpnOT7cldVwHob4AvW5rV_0nycXCzi4w2Dusb8713qPpDckEEk2_joZyxEZ1gPJAT8gP_jIXe</recordid><startdate>201105</startdate><enddate>201105</enddate><creator>Ito, Kosei</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope></search><sort><creationdate>201105</creationdate><title>RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers</title><author>Ito, Kosei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4957-b0505b26f8705b1c1b4e832bd881111e01265d64ea85fe1c30c61357f74eae6e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Apoptosis - genetics</topic><topic>BMP</topic><topic>Cell Adhesion - genetics</topic><topic>Core Binding Factor Alpha 3 Subunit - genetics</topic><topic>Core Binding Factor Alpha 3 Subunit - metabolism</topic><topic>gastrointestinal cancers</topic><topic>Gastrointestinal Neoplasms - genetics</topic><topic>Gastrointestinal Neoplasms - metabolism</topic><topic>Gastrointestinal Neoplasms - pathology</topic><topic>Helicobacter pylori</topic><topic>Humans</topic><topic>Intestinal Mucosa - metabolism</topic><topic>Mice</topic><topic>RUNX3</topic><topic>Signal Transduction - genetics</topic><topic>TGF-beta</topic><topic>Transforming Growth Factor beta - genetics</topic><topic>Transforming Growth Factor beta - metabolism</topic><topic>Tumor Suppressor Proteins - genetics</topic><topic>Tumor Suppressor Proteins - metabolism</topic><topic>Wnt</topic><topic>Wnt Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ito, Kosei</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ito, Kosei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2011-05</date><risdate>2011</risdate><volume>112</volume><issue>5</issue><spage>1243</spage><epage>1249</epage><pages>1243-1249</pages><issn>0730-2312</issn><issn>1097-4644</issn><eissn>1097-4644</eissn><abstract>The reputation of RUNX3 as a strong candidate for a tumor suppressor originated from studies of gastric carcinogenesis and now extends to a variety of other human cancers. The RUNX3 transcription factor is a downstream effector of the TGF‐β superfamily signaling pathway and has a critical role in the regulation of cell proliferation, cell death by apoptosis, and cell adhesion. Recently, RUNX3 was proposed as a gatekeeper linking oncogenic Wnt and anti‐oncogenic TGF‐β/BMPs signaling pathways in intestinal tumorigenesis in mouse and human. Also, loss of RUNX3 leading to elevated oncogenic Wnt activity was found to be a key event in inducing a precancerous state of the stomach. Chronic Helicobacter pylori infection is reported to inactivate RUNX3 in gastric carcinogenesis by multiple mechanisms. This “Prospect” focuses on our current understanding of the tumor suppressive functions of RUNX3 in the context of gastrointestinal cancer initiation and progression. J. Cell. Biochem. 112: 1243–1249, 2011. © 2011 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>21465522</pmid><doi>10.1002/jcb.23047</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0730-2312 |
ispartof | Journal of cellular biochemistry, 2011-05, Vol.112 (5), p.1243-1249 |
issn | 0730-2312 1097-4644 1097-4644 |
language | eng |
recordid | cdi_proquest_miscellaneous_907169153 |
source | Wiley Online Library - AutoHoldings Journals; MEDLINE |
subjects | Animals Apoptosis - genetics BMP Cell Adhesion - genetics Core Binding Factor Alpha 3 Subunit - genetics Core Binding Factor Alpha 3 Subunit - metabolism gastrointestinal cancers Gastrointestinal Neoplasms - genetics Gastrointestinal Neoplasms - metabolism Gastrointestinal Neoplasms - pathology Helicobacter pylori Humans Intestinal Mucosa - metabolism Mice RUNX3 Signal Transduction - genetics TGF-beta Transforming Growth Factor beta - genetics Transforming Growth Factor beta - metabolism Tumor Suppressor Proteins - genetics Tumor Suppressor Proteins - metabolism Wnt Wnt Proteins - metabolism |
title | RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T04%3A10%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RUNX3%20in%20oncogenic%20and%20anti-oncogenic%20signaling%20in%20gastrointestinal%20cancers&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Ito,%20Kosei&rft.date=2011-05&rft.volume=112&rft.issue=5&rft.spage=1243&rft.epage=1249&rft.pages=1243-1249&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.23047&rft_dat=%3Cproquest_cross%3E907169153%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=907169153&rft_id=info:pmid/21465522&rfr_iscdi=true |